Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lewis R Roberts

Showing results (221-230 of 393) with videos related to

Pageof 40
Sort By:
Gastroenterology|December 20, 2011
Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitorsJesper B Andersen, Bart Spee, Boris R Blechacz, et al.
Cancer Medicine|November 20, 2018
Hypothyroidism is associated with worse outcomes of hepatocellular carcinoma patients after liver transplantationNing Zhang, Weidong Jin, Shuangnan Zhou, et al.
Medical Epigenetics|August 4, 2015
Restoration of epigenetically silenced SULF1 expression by 5-aza-2-deoxycytidine sensitizes hepatocellular carcinoma cells to chemotherapy-induced apoptosisAbdirashid Shire, Gwen Lomberk, Jin-Ping Lai, et al.
Cancer Cytopathology|July 11, 2013
Primary sclerosing cholangitis with equivocal cytology: fluorescence in situ hybridization and serum CA 19-9 predict risk of malignancyEmily G Barr Fritcher, Jesse S Voss, Sarah M Jenkins, et al.
Gastrointestinal Endoscopy|December 20, 2015
Fluorescence in situ hybridization compared with conventional cytology for the diagnosis of malignant biliary tract strictures in Asian patientsRoongruedee Chaiteerakij, Emily G Barr Fritcher, Phonthep Angsuwatcharakon, et al.
Carcinogenesis|September 14, 2012
Metallothionein MT1M is a tumor suppressor of human hepatocellular carcinomasJun Mao, Hongxiu Yu, Chenji Wang, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|March 18, 2026
Comprehensive molecular-clinical profiling of cholangiocarcinoma according to pathologic subtypesKeun Soo Ahn, Daniel O'Brien, Yoo Na Kang, et al.
Oncogene|July 9, 2002
Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomasKen Taniguchi, Lewis R Roberts, Ileana N Aderca, et al.
Journal of Hepatocellular Carcinoma|March 25, 2026
Real-World Analysis of Multidisciplinary Roles in the Management of Hepatocellular Carcinoma: The Mayo Clinic ExperienceFatima Z Islam, Cynthia De La Garza-Ramos, Umair Majeed, et al.
Hepatology International|June 20, 2019
Prognostic subclass of intrahepatic cholangiocarcinoma by integrative molecular-clinical analysis and potential targeted approachKeun Soo Ahn, Daniel O'Brien, Yu Na Kang, et al.
Pageof 40

Showing results (221-230 of 393) with videos related to

Sort By:
Pageof 40
Gastroenterology|December 20, 2011
Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitorsJesper B Andersen, Bart Spee, Boris R Blechacz, et al.
Cancer Medicine|November 20, 2018
Hypothyroidism is associated with worse outcomes of hepatocellular carcinoma patients after liver transplantationNing Zhang, Weidong Jin, Shuangnan Zhou, et al.
Medical Epigenetics|August 4, 2015
Restoration of epigenetically silenced SULF1 expression by 5-aza-2-deoxycytidine sensitizes hepatocellular carcinoma cells to chemotherapy-induced apoptosisAbdirashid Shire, Gwen Lomberk, Jin-Ping Lai, et al.
Cancer Cytopathology|July 11, 2013
Primary sclerosing cholangitis with equivocal cytology: fluorescence in situ hybridization and serum CA 19-9 predict risk of malignancyEmily G Barr Fritcher, Jesse S Voss, Sarah M Jenkins, et al.
Gastrointestinal Endoscopy|December 20, 2015
Fluorescence in situ hybridization compared with conventional cytology for the diagnosis of malignant biliary tract strictures in Asian patientsRoongruedee Chaiteerakij, Emily G Barr Fritcher, Phonthep Angsuwatcharakon, et al.
Carcinogenesis|September 14, 2012
Metallothionein MT1M is a tumor suppressor of human hepatocellular carcinomasJun Mao, Hongxiu Yu, Chenji Wang, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|March 18, 2026
Comprehensive molecular-clinical profiling of cholangiocarcinoma according to pathologic subtypesKeun Soo Ahn, Daniel O'Brien, Yoo Na Kang, et al.
Oncogene|July 9, 2002
Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomasKen Taniguchi, Lewis R Roberts, Ileana N Aderca, et al.
Journal of Hepatocellular Carcinoma|March 25, 2026
Real-World Analysis of Multidisciplinary Roles in the Management of Hepatocellular Carcinoma: The Mayo Clinic ExperienceFatima Z Islam, Cynthia De La Garza-Ramos, Umair Majeed, et al.
Hepatology International|June 20, 2019
Prognostic subclass of intrahepatic cholangiocarcinoma by integrative molecular-clinical analysis and potential targeted approachKeun Soo Ahn, Daniel O'Brien, Yu Na Kang, et al.
Pageof 40